Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lifecore Biomedical, Inc. - Common Stock (NQ: LFCR )

6.330 +0.010 (+0.16%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 104,697
Open 6.400
Bid (Size) 5.900 (2)
Ask (Size) 6.480 (20)
Prev. Close 6.320
Today's Range 6.002 - 6.430
52wk Range 4.470 - 11.46
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Lifecore Biomedical, Inc. (LFCR) Investors
From Law Offices of Howard G. Smith
Via Business Wire
LIFECORE BIOMEDICAL, INC. (NASDAQ: LFCR) INVESTOR ALERT: Investors With Large Losses in Lifecore Biomedical Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
From Bernstein Liebhard LLP
Via GlobeNewswire

Performance

YTD
-0.78%
-0.78%
1 Month
+34.11%
+34.11%
3 Month
-1.40%
-1.40%
6 Month
-6.64%
-6.64%
1 Year
-39.48%
-39.48%

More News

Read More
LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Lifecore Biomedical, Inc. Investors
From Kirby McInerney LLP
Via Business Wire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore
From Faruqi & Faruqi LLP
Via GlobeNewswire
LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
LFCR INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Lifecore Biomedical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
Rosen Law Firm Urges Lifecore Biomedical, Inc. (NASDAQ: LFCR) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
Lifecore Biomedical Announces Cooperation Agreement with 22NW
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical Completes Incremental Liquidity Initiatives
From Lifecore Biomedical, Inc.
Via GlobeNewswire
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
ROSEN, A LEADING LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
ROSEN, A LEADING LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
ROSEN, A LEADING LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC
From The Rosen Law Firm PA
Via GlobeNewswire
ROSEN, A LEADING NATIONAL FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
ROSEN, A LEADING NATIONAL FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
ROSEN, A TOP RANKED LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC
From The Rosen Law Firm PA
Via GlobeNewswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.